People

Ryan Marques Joins Elutia as VP of Operations

Marques previously served as head of U.S. Operations at Nobelpharma America.

By: Michael Barbella

Managing Editor

Elutia Inc. has appointed Ryan Marques, Ph.D, as vice president of Operations. He has more than 20 years of experience leading operations teams across manufacturing, quality assurance, supply chain, and technical services in the medical device and pharmaceutical industries.
 
“We are pleased to welcome Ryan to the Elutia CRU as our new vice president of Operations,” Elutia CEO Dr. Randy Mills said. “At Elutia, culture matters, and Ryan has both the experience and character to make him an excellent fit and an effective leader within our growing organization. His extensive operational and manufacturing expertise across both pharma and devices will be instrumental as we launch EluPro, the world’s first FDA-cleared antibiotic-eluting BioEnvelope, in the second half of 2024.”
 
Before joining Elutia, Dr. Marques was the head of U.S. Operations at Nobelpharma America, a pharmaceutical and medical device company that develops rare and neglected diseas treatments. Before that, he led operations at Next Breath Inc./Aptar Pharma, a contract services provider for pharmaceutical, biotech, and medical device companies, as well as at Canon BioMedical, a medical diagnostics company. Dr. Marques began his industry career by managing manufacturing and technical operations at QIAGEN.

Dr. Marques completed his post-doctoral training at the University of Maryland (Center for Vaccine Development) and earned a Ph.D. in molecular microbiology/immunology and an MBA from the Robert H. Smith School of Business, University of Maryland.
 
“I am honored to join Elutia at such an important time for the company,” Dr. Marques stated. “I am excited to be working as part of the Elutia team as we launch EluPro and expand our production capacity for the current product offerings as well as new drug-eluting biomatrix products in development.”
 
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. The firm is based in Silver Spring, Md. 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters